Molecular Pathogenesis of Prostate Cancer

Abstract

Prostate cancer is the second most common cause of death in men worldwide, after lung carcinoma. Although early treatment and preventive medicine practices came to the fore in the era of PSA follow-up, and subsequent needle biopsies made it easier to detect the tumor development of the patients, but we did not have much chance in terms of determining the behavior of the tumor especially before, during and after the treatment, except for risk scoring schemes. Today, the molecular signature and molecular biology of the disease, which we can use to determine individual treatment models and to predict the prognosis of the disease, are important. For all these reasons, medical professional's knowledge of the molecular pathogenesis and biological attitude of prostate cancer will help to understand the disease and its course.